Skip to content

Effect of intraoperative dexmedetomidine on the incidence of nausea and vomiting in adult patients after gynecologic laparoscopic surgery: a randomized controlled trial

Effect of intraoperative dexmedetomidine on the incidence of nausea and vomiting in adult patients after gynecologic laparoscopic surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006914
Enrollment
Unknown
Registered
2015-08-11
Start date
2014-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecologic laparoscopic surgery

Interventions

Two groups:dexmedetomidine versus control

Sponsors

Peking University, First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
23 Years to 60 Years

Inclusion criteria

Inclusion criteria: ASA physical status I or II patients, between 18 and 65 yr old, undergoing elective laparoscopic gynecological surgery were enrolled for removal of ovarian tumors and cysts, myomectomy, and laparoscopic assisted vaginal hysterectomy.

Exclusion criteria

Exclusion criteria: Exclusion criteria included age65 years, a history of uncontrolled hypertension, heart block greater than first degree, obesity (body mass index >30 kg/m2), pregnancy, breast-feeding, known hypersensitivity to drugs used in the study protocol, use of antiemetics, psychotropic drugs and steroids within 24h before surgery. Patients with known comorbidities that could increase the incidence of PONV were also excluded, such as diseases which impaired gastric motility (gastric and intestinal disease, neuromuscular disorders, neuropathies, and liver dysfunction), vestibular disease, central nervous system injury, renal impairment, alcoholism, and opioid addiction.

Design outcomes

Primary

MeasureTime frame
incidence of 24h PONV;

Countries

China

Contacts

Public ContactWang Dongxin
wangdongxin@hotmail.com+86 010-83572784

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026